New England Research & Management, Inc. Astrazeneca PLC Transaction History

New England Research & Management, Inc.

$197 Million
Q1 2025

A detailed history of New England Research & Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, New England Research & Management, Inc. holds 15,950 shares of AZN stock, worth $1.13 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

15,950

Previous 6,150 159.35%

Holding current value

$1.13 Million

Previous $403,000 190.82%

% of portfolio

0.6%

Previous 0.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$65.37 - $77.96 $640,626 - $764,007	9,800 Added 159.35%	15,950 $1.17 Million
Q2 2024 Jul 09, 2024	SELL	$66.81 - $80.83 $13,362 - $16,166	-200 Reduced 3.15%	6,150 $480,000
Q4 2023 Feb 06, 2024	SELL	$61.89 - $69.28 $18,567 - $20,784	-300 Reduced 4.51%	6,350 $428,000
Q1 2023 Apr 06, 2023	SELL	$63.15 - $71.6 $12,630 - $14,319	-200 Reduced 2.92%	6,650 $462,000
Q2 2022 Jul 20, 2022	SELL	$59.26 - $71.14 $278,522 - $334,358	-4,700 Reduced 40.69%	6,850 $453,000
Q1 2022 Apr 20, 2022	SELL	$55.72 - $67.12 $238,203 - $286,938	-4,275 Reduced 27.01%	11,550 $766,000
Q4 2021 Jan 05, 2022	SELL	$54.02 - $63.83 $221,482 - $261,703	-4,100 Reduced 20.58%	15,825 $922,000
Q3 2021 Oct 08, 2021	BUY	$55.56 - $60.79 $209,739 - $229,482	3,775 Added 23.37%	19,925 $1.2 Million
Q2 2021 Jul 15, 2021	SELL	$48.42 - $60.18 $251,784 - $312,936	-5,200 Reduced 24.36%	16,150 $967,000
Q1 2021 Apr 16, 2021	SELL	$47.16 - $54.44 $5,895 - $6,805	-125 Reduced 0.58%	21,350 $1.06 Million
Q4 2020 Jan 07, 2021	BUY	$48.52 - $58.02 $762,977 - $912,364	15,725 Added 273.48%	21,475 $1.07 Million
Q3 2020 Oct 08, 2020	SELL	$53.07 - $61.1 $8,331 - $9,592	-157 Reduced 2.66%	5,750 $315,000
Q4 2018 Jan 11, 2019	SELL	$36.86 - $41.49 $3,686 - $4,149	-100 Reduced 1.66%	5,907 $224,000
Q1 2018 Apr 17, 2018	SELL	$32.97 - $36.63 $46,158 - $51,282	-1,400 Reduced 18.9%	6,007 $210,000
Q4 2017 Jan 09, 2018	SELL	$32.09 - $34.78 $301,646 - $326,932	-9,400 Reduced 55.93%	7,407 $257,000
Q3 2017 Oct 25, 2017	BUY	$28.96 - $34.0 $486,730 - $571,438	16,807	16,807 $569,000

Others Institutions Holding AZN

# of Institutions

1,428

Shares Held

504M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account

New England Research & Management, Inc. Astrazeneca PLC Transaction History